| Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175) |
|---|
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | US20050043569 preparing an amidine by reacting a NH group-containing compound with a nitrile in the presence of a silylating agent (trimethylsilyl trifluoromethanesulfonate); direct and efficient synthesis ; large-scale synthesis. |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/23/2005 | CN1190416C Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn. and use |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/17/2005 | US20050038117 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 02/17/2005 | US20050035267 Furnace mount and method of installation |
| 02/17/2005 | US20050035266 Furnace Mount and Method of Installation |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | US20050033085 Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide of isothiouronium bromide equivalents as intermediates |
| 02/10/2005 | US20050032849 Substituted small-molecule arylthiourea compounds are potent and/or selective inhibitors of viral replication in vivo, particularly Hepatitis C virus replication; e.g., 1-(3-benzyloxy)phenylthiourea; side effect reduction |
| 02/09/2005 | EP1280525B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/02/2005 | EP1501789A1 Amidinylphenyl compounds and their use as fungicides |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007601A2 Substituted arylthiourea derivatives useful as inhibitors of viral replication |
| 01/26/2005 | EP1117409B1 Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/13/2005 | WO2005003084A1 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
| 01/13/2005 | WO2003078390A8 Phenolic compound and recording material containing the same |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | CA2533547A1 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
| 01/12/2005 | CN1564812A Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates |
| 01/12/2005 | CN1562967A Method for synthesizing dextrorotation S-(2-amido propyl)-methyl isothiurothiuronium salts |
| 01/06/2005 | WO2005000803A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/04/2005 | US6838472 Substituted urea retinoid agonists |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | EP1491529A1 Phenolic compound and recording material containing the same |
| 12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
| 12/23/2004 | WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/23/2004 | DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds |
| 12/16/2004 | US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/15/2004 | CN1555359A Alkyl urea vitamin A protagonist i |
| 12/15/2004 | CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii |
| 12/15/2004 | CN1554645A New process for synthesizing thiourea dioxide |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/09/2004 | WO2004106292A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
| 12/09/2004 | WO2004106291A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
| 12/09/2004 | US20040249150 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/09/2004 | CA2568609A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
| 12/09/2004 | CA2568607A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
| 12/09/2004 | CA2527785A1 Ionic liquid comprising uronium cations or thiouronium cations |
| 12/08/2004 | EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 12/02/2004 | WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 12/02/2004 | WO2004103281A2 Vanilloid receptor antagonists, and methods of making and using them |
| 12/02/2004 | WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors |
| 12/02/2004 | CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 12/01/2004 | EP1480957A1 Hppars activators |
| 12/01/2004 | EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors |
| 11/25/2004 | WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 11/25/2004 | US20040235792 For inhibiting urokinase in therapy of disease |
| 11/25/2004 | US20040235023 For chemoselective, regioselective, stereoselective or enantioselective transformation; solid phase synthesis |
| 11/18/2004 | US20040229955 Antibacterial agents |
| 11/18/2004 | US20040229949 New 3-aryl propionic acid derivatives and analogs |
| 11/18/2004 | US20040229946 Antidiabetic agents |
| 11/17/2004 | EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 11/16/2004 | US6818765 Benzene-sulphonamide derivatives and their uses |
| 11/16/2004 | US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 11/10/2004 | EP1474380A2 4-dedimethylamino tetracycline compounds |
| 11/03/2004 | EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto |
| 11/03/2004 | EP0798292B1 Aniline derivatives having nitrogen monoxide synthase inhibitory activity |
| 11/02/2004 | US6812218 Transferring nucleic acids to cells |
| 10/28/2004 | US20040214801 9-Substituted minocycline compounds |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
| 10/21/2004 | US20040209948 especially naphthalene sulfonamides, used for treating asthma |
| 10/19/2004 | US6806365 N-alkanoylphenylalamine derivatives |
| 10/19/2004 | US6806292 Substituted imide derivatives |
| 10/14/2004 | US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators |
| 10/12/2004 | US6803472 Method for preparing nitrogen containing compounds |
| 10/07/2004 | US20040198777 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; antiproliferative agents; anticancer agents; antiepileptic agents; deafness |
| 09/30/2004 | WO2004058683A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 09/29/2004 | CN1168712C Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4- methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 09/22/2004 | EP1458831A2 Composition containing a polymerizable reducing agent, kit, and method |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/15/2004 | EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/10/2004 | WO2004075841A2 Process for preparing benzhydrylthioacetamide |
| 09/10/2004 | CA2511992A1 Process for preparing benzhydrylthioacetamide |
| 09/09/2004 | US20040176334 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 09/09/2004 | US20040176253 Herbicides; broad active spectrum; on soil and above ground plant parts use |
| 09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
| 08/25/2004 | CN1524075A Substitued arylketones |
| 08/25/2004 | CN1163491C 3-amino-2-mercapto benzoic acid derivative and its preparation method |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/17/2004 | CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/05/2004 | WO2004065353A1 Compounds for the inhibition of rotamases |